All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Does low testosterone really cause depression in women?

Alixa Winn

TikTok creator

70.7K viewsWatch on TikTok→

Quick answer

Testosterone does decline with age in women and some trial data supports its use for sexual dysfunction in postmenopausal women, but no FDA-approved testosterone product exists for women in the U.S., and evidence for testosterone as a treatment for depression or anxiety remains inconsistent across randomized trials. The Endocrine Society's 2014 guidelines do not recommend testosterone for mood disorders in women due to insufficient evidence. Any evaluation of mood symptoms in perimenopausal women should include a full differential, including estrogen status, thyroid function, sleep quality, and psychiatric history, before attributing symptoms to low testosterone.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.

What's this video probably claiming?

Based on the caption, this creator is telling her audience that low testosterone in women can masquerade as depression and anxiety, particularly in perimenopause and midlife. She's framing her own experience as a diagnostic revelation: she thought she had depression, got her hormones tested, and started testosterone replacement therapy (TRT). The implication is that if you're a woman suddenly experiencing mood symptoms in midlife, you may be misdiagnosed, and the real culprit could be a hormonal deficit rather than a psychiatric condition. This is a narrative that's gained significant traction in the wellness-TikTok ecosystem, and it contains enough partial truth to be genuinely confusing for the 70,000-plus people who've seen it.

What does the science actually show?

The relationship between testosterone and mood in women is real but complicated. Testosterone levels do decline with age, dropping roughly 50% between ages 20 and 45 (Davis et al., 2005, Journal of Clinical Endocrinology and Metabolism). Some observational data suggests low androgen levels correlate with depressive symptoms, fatigue, and reduced wellbeing in perimenopausal women. A randomized controlled trial by Davis et al. (2008, Menopause) found transdermal testosterone at 300 mcg/day improved mood and sexual function in surgically menopausal women versus placebo. However, the evidence for testosterone treating depression as a primary indication is much weaker. A 2019 Cochrane-adjacent systematic review by Islam et al. (Journal of Clinical Endocrinology and Metabolism) found benefits for sexual function were consistent but mood effects were modest and inconsistent across trials. The FDA has not approved any testosterone formulation for women in the United States for any indication, including depression.

Where does the social media noise diverge from clinical reality?

Here's where the video likely oversimplifies. The creator's framing, that new-onset depression in midlife could "very well be" your hormones, skips over a long list of alternative explanations. Perimenopause is also characterized by estrogen and progesterone fluctuations, sleep disruption, and cortisol dysregulation, all of which independently drive mood symptoms. Attributing depression specifically to testosterone, rather than to the broader hormonal milieu, is a significant leap. There's also a real diagnostic risk here. Women who self-advocate for testosterone testing and receive TRT without proper psychiatric evaluation may delay treatment for genuine depressive disorders, which have well-established, evidence-backed treatments. The SWAN study (Bromberger et al., 2011, Archives of General Psychiatry) found that perimenopausal women had a twofold increased risk of clinical depression compared to premenopausal women, and that risk was not simply explained by androgen levels.

What should you actually know?

If you're a woman in midlife experiencing new-onset depression or anxiety, getting a full hormonal panel is a reasonable part of a workup. But it's one data point, not a diagnosis. Testosterone reference ranges for women vary significantly between labs, there is no universally agreed-upon threshold for "low" testosterone in women, and symptoms don't reliably correlate with serum levels. The Endocrine Society's 2014 clinical practice guideline specifically states there is insufficient evidence to recommend testosterone therapy for women with mood disorders. If you're working with a telehealth provider, any testosterone prescription should come after a thorough clinical history, not just a lab value. TRT in women, typically dosed at 0.5 to 2 mg/day topically, carries real side effects including acne, hair loss, and voice changes at higher doses. A TikTok testimonial is not a treatment plan.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

TRT social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Does low testosterone really cause depression in women?, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Does low testosterone really cause depression in women? should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

Use the health tools and supporting evidence to prepare questions for your clinician.

Claim path

Keep researching this testosterone and trt video claims cluster

Best for searchers turning TRT social claims into a safer lab-backed provider discussion.

Claim verdict

The useful answer behind this video

Claim being checked

Testosterone does decline with age in women and some trial data supports its use for sexual dysfunction in postmenopausal women, but no FDA-approved testosterone product exists for women in the U.

FormBlends verdict

Testosterone does decline with age in women and some trial data supports its use for sexual dysfunction in postmenopausal women, but no FDA-approved testosterone product exists for women in the U.S., and evidence for testosterone as a treatment for depression or anxiety remains inconsistent across randomized trials. The Endocrine Society's 2014 guidelines do not recommend testosterone for mood disorders in women due to insufficient evidence. Any evaluation of mood symptoms in perimenopausal women should include a full differential, including estrogen status, thyroid function, sleep quality, and psychiatric history, before attributing symptoms to low testosterone.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Testosterone does decline with age in women and some trial data supports its use for sexual dysfunction in postmenopausal women, but no FDA-approved testosterone product exists for women in the U.S., and evidence for testosterone as a treatment for depression or anxiety remains inconsistent across randomized trials. The Endocrine Society's 2014 guidelines do not recommend testosterone for mood disorders in women due to insufficient evidence. Any evaluation of mood symptoms in perimenopausal women should include a full differential, including estrogen status, thyroid function, sleep quality, and psychiatric history, before attributing symptoms to low testosterone.
  • Testosterone levels in women decline roughly 50% between ages 20 and 45, but there is no universally agreed-upon clinical threshold for deficiency in women.
  • The FDA has not approved any testosterone product for women in the United States, including for depression, anxiety, or mood disorders.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Testosterone levels in women decline roughly 50% between ages 20 and 45, but there is no universally agreed-upon clinical threshold for deficiency in women.
  • The FDA has not approved any testosterone product for women in the United States, including for depression, anxiety, or mood disorders.
  • Randomized trial evidence supports testosterone for sexual dysfunction in surgically menopausal women, but mood benefits are secondary and inconsistent across studies.
  • Perimenopausal depression risk is approximately twofold higher than in premenopausal women, driven by estrogen fluctuations, sleep disruption, and cortisol changes, not testosterone alone.
  • The Endocrine Society's 2014 guidelines do not recommend testosterone therapy for mood disorders in women due to insufficient evidence.
  • Side effects of testosterone in women include acne, hair loss, and irreversible voice deepening at higher doses, risks that are rarely discussed in social media content.
  • New-onset depression in midlife warrants a full clinical evaluation including thyroid, estrogen, and psychiatric history, not a single hormone test followed by a prescription.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Alixa Winn · TikTok creator

70.7K views on this video

sounds crazy, but low testosterone levels in women present as depression and anxiety. if you've never had depression before, and all of a sudden in midlife it starts presenting, it could very well be your hormones. I thought I was depressed too, got my hormones checked, started Testosterone replacement therapy and I was immediately happier and more motivated than I ever have been. after six years of treatment I feel amazing. I'm so happy. im confident. and I wake up excited and ready to tackle

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Alixa Winn, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.